ARCHIVES

NCI “Leadership Vacuum” Deepened?

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

Oblimersen Combination Improves CLL Survival

December 28, 2007

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB

September 28, 1979

NCI Clinical Alert Urges Patients To Seek Care From Specialists.

January 20, 2006

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993